Gilead prices remdesivir at $2,340 per patient for developed countries

0
1

Gilead has announced that the potential COVID-19 drug remdesivir will cost $390 per vial for developed countries, with treatment courses costing $2,340 per patient.

In an open letter from Daniel O’Day, Gilead Science’s Chairman and Chief Executive Officer (CEO), the company has outlined how much they will charge for remdesivir, a medicine currently being used as a COVID-19 treatment under certain conditions and investigated in clinical trials.

According to O’Day, the company has set a price for remdesivir for governments of developed countries at $390 per vial. He added that based on current treatment patterns, the majority of patients are expected to receive a five day treatment course using six vials of remdesivir, which equates to $2,340 per patient. This price will be offered to all governments in developed countries around the world where remdesivir is approved or authorised for use.

O’Day explains that in the US, the same government price of $390 per vial will apply. However, because of the way the country’s system is set up and the discounts that government healthcare programmes expect, the price for private insurance companies in the US will be $520 per vial.

In the developing world, where healthcare resources, infrastructure and economics are so different, the company has entered into agreements with generic manufacturers to deliver the treatment at a substantially lower cost. According to O’Day, these alternative solutions are designed to ensure that all countries in the world can provide access to treatment.

“As with all our actions on remdesivir, we approached this with the aim of helping as many patients as possible, as quickly as possible and in the most responsible way. This has been our compass point throughout, from collaborating to find rapid answers on safety and efficacy, to scaling up manufacturing and donating our supply of remdesivir through the end of June,” wrote O’Day.

The letter highlights that Gilead made their decision partly to remove the need for country by country negotiations on price. O’Day also said that the price has been discounted to a level that is affordable for developed countries with the lowest purchasing power.

“In making our decision on how to price remdesivir, we considered the full scope of our responsibilities. We started with our immediate responsibility to ensure price is in no way a hindrance to ensuring rapid and broad treatment. We also balanced that with our longer-term responsibilities: to continue with our ongoing work on remdesivir, to maintain our long-term research in antivirals and to invest in scientific innovation that might help generations to come,” O’Day wrote.

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorised as ”Necessary” are stored on your browser as they are as essential for the working of basic functionalities of the website. For our other types of cookies “Advertising & Targeting”, “Analytics” and “Performance”, these help us analyse and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these different types of cookies. But opting out of some of these cookies may have an effect on your browsing experience. You can adjust the available sliders to ‘Enabled’ or ‘Disabled’, then click ‘Save and Accept’. View our Cookie Policy page.

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category “Advertising & Targeting”.

This cookie is set by GDPR Cookie Consent WordPress Plugin. The cookie is used to remember the user consent for the cookies under the category “Analytics”.

This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category “Necessary”.

This cookie is set by GDPR Cookie Consent WordPress Plugin. The cookie is used to remember the user consent for the cookies under the category “Performance”.

This cookie is native to PHP applications. The cookie is used to store and identify a users’ unique session ID for the purpose of managing user session on the website. The cookie is a session cookies and is deleted when all the browser windows are closed.

The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

This session cookie is served by our membership/subscription system and controls whether you are able to see content which is only available to logged in users.

The cookie is set by CloudFare. The cookie is used to identify individual clients behind a shared IP address and apply security settings on a per-client basis. It does not correspond to any user ID in the web application and does not store any personally identifiable information.

Performance cookies are includes cookies that deliver enhanced functionalities of the website, such as caching. These cookies do not store any personal information.

This cookie is set by Cloudflare content delivery network and, in conjunction with the cookie ‘cf_use_ob’, is used to determine whether it should continue serving “Always Online” until the cookie expires.

This cookie is set by Cloudflare content delivery network and is used to determine whether it should continue serving “Always Online” until the cookie expires.

This session cookie is served by our membership/subscription system and controls which types of content you are able to access.

This cookie is set by Litespeed Server and allows the server to store settings to help improve performance of the site.

This cookie is set by OneSignal push notifications and is used for storing user preferences in connection with their notification permission status.

This cookie is set by Youtube and is used to track the views of embedded videos.

Analytics cookies collect information about your use of the content, and in combination with previously collected information, are used to measure, understand, and report on your usage of this website.

This cookie is set by LinkedIn. The purpose of the cookie is to enable LinkedIn functionalities on the page.

This cookie is set by YouTube and registers a unique ID for tracking users based on their geographical location

This cookie is set by LinkedIn and is used to store the language preferences of a user to serve up content in that stored language the next time user visit the website.

We embed videos from our official Vimeo channel. When you press play, Vimeo will drop third party cookies to enable the video to play and to see how long a viewer has watched the video. This cookie does not track individuals.

This cookie is set by Spotler and enables it to track the Load Balance Session Queue.

This cookie is set by Spotler and stores the UTM values for the session. UTM values are specific text strings that are appended to URLs that allow Communigator to track the URLs and the UTM values when they get clicked on.

This cookie is set by Google Analytics and is used to calculate visitor, session, campaign data and keep track of site usage for the site’s analytics report. It stores information anonymously and assign a randomly generated number to identify unique visitors.

This cookies is set by Google Universal Analytics to throttle the request rate to limit the collection of data on high traffic sites.

This cookie is set by Google Analytics and is used to store information of how visitors use a website and helps in creating an analytics report of how the website is doing. The data collected including the number visitors, the source where they have come from, and the pages visited in an anonymous form.

This cookie is set by Advanced Ads and sets geo-location, user role and user capabilities. It is used by cache busting in Advanced Ads Pro when the appropriate visitor conditions are used.

This cookie is set by Google DoubleClick and stores information about how the user uses the website and any other advertisement before visiting the website. This is used to present users with ads that are relevant to them according to the user profile.

This cookie is set by Linkedin and is used to track visitors on multiple websites, in order to present relevant advertisement based on the visitor’s preferences.

This cookie is set by YouTube. Used to track the information of the embedded YouTube videos on a website.

Source: https://www.europeanpharmaceuticalreview.com/news/122592/gilead-prices-remdesivir-at-2340-per-patient-for-developed-countries/

World news – GB – Gilead prices remdesivir at $2,340 per patient for developed countries

LEAVE A REPLY

Please enter your comment!
Please enter your name here